These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Reply. Kastritis E. et al. Reversibility of renal failure in newly diagnosed multiple myeloma patients treated with high dose dexamethasone containing regimes and the impact of novel agents. Haematologica 2007; 92:546-9. Bergner R; Hoffmann M; Uppenkamp M Haematologica; 2008 Jan; 93(1):e18-9. PubMed ID: 18166771 [No Abstract] [Full Text] [Related]
7. Nonsecretory myeloma. A case report. Moehring HD Clin Orthop Relat Res; 1982; (171):196-201. PubMed ID: 7140070 [TBL] [Abstract][Full Text] [Related]
8. Inpatient rehabilitation in persons with multiple myeloma-associated fractures: an analysis of 8 consecutive inpatient admissions. Cheng DS; O'Dell MW PM R; 2011 Jan; 3(1):78-84. PubMed ID: 21257138 [No Abstract] [Full Text] [Related]
9. Dosing chemotherapy agents in hemodialysis--a focus on multiple myeloma. Runnels R; Cameron K; Ng P; Battistella M CANNT J; 2014; 24(1):21-5; quiz 26-7. PubMed ID: 24783769 [No Abstract] [Full Text] [Related]
10. Disodium pamidronate for treating severe hypercalcemia in a hemodialysis patient. Trimarchi H; Lombi F; Forrester M; Elizondo C; Sawinski D; Pereyra H; Freixas E Nat Clin Pract Nephrol; 2006 Aug; 2(8):459-63; quiz 464. PubMed ID: 16932480 [TBL] [Abstract][Full Text] [Related]
11. [Prognostic factors in multiple myeloma]. Boccadoro M; Bianchi A; Dianzani U; Frieri R; Gallone G; Massaia M; Omede P; Palumbo A; Pileri A Haematologica; 1989 Oct; 74(5 Suppl):347-57. PubMed ID: 2512219 [No Abstract] [Full Text] [Related]
13. Effectiveness of two-stage treatment of multiple myeloma with melphalan and with melphalan in combination with cyclophosphamide, carmustine, vincristine and prednisone. Snigurowicz J; Kraj M; Rostkowska J; Maj S; Mariańska B; Mendek E; Roszkowski S; Kilian Z; Kołakowski L Arch Immunol Ther Exp (Warsz); 1981; 29(2):145-53. PubMed ID: 7030265 [No Abstract] [Full Text] [Related]
14. Aggressive plasma cell myeloma. A terminal phase. Suchman AL; Coleman M; Mouradian JA; Wolf DJ; Saletan S Arch Intern Med; 1981 Sep; 141(10):1315-20. PubMed ID: 7271406 [TBL] [Abstract][Full Text] [Related]
15. [Renal insufficiency in myelomatosis. Prognostic factors and survival]. Gregersen H; Ibsen JS; Nielsen M Ugeskr Laeger; 1997 May; 159(22):3387-92. PubMed ID: 9199025 [TBL] [Abstract][Full Text] [Related]